seekingalpha.com · 26 jun

Cognition Therapeutics: Clearer FDA Path, But Potential Dilution Risks Remain

Cognition Therapeutics is currently prioritizing zervimesine for DLB psychosis. This is after the FDA's feedback gave their planned pivotal program a clearer path. Basically, DLB psychosis has no approved therapy, and zervimesine is a promising oral once-daily drug that already has interesting Phase 2 data. CGTX's SHIMMER trial was a good start, but their next trial must confirm longer-lasting hallucination and delusion benefits.

globenewswire.com · 24 jun

Cognition Therapeutics Aligns on Key Aspects of Pivotal Study for Zervimesine (CT1812) in DLB Psychosis Following Receipt of FDA Meeting Minutes

- Zervimesine Would be the First Long-term, Durable Treatment Option with an Impact on Underlying Disease - - Company Developing NPI as a Measure of DLB Psychosis -

zacks.com · 10 jun

3 Audio Video Stocks to Watch as Industry Witnesses Headwinds

Amid cautious discretionary spending and macro troubles, investments in cutting-edge solutions are likely to aid Zacks Audio Video Production industry participants like SONY, DLB and SONO.

gurufocus.com · 9 jun

Arista Introduces Next-Generation 1.6Terabit Portfolio for AI Fabrics

Arista Networks (NYSE: ANET), a leader in modern AI fabric networking, today announced the Arista [url="]7060XE7 Series[/url], a new portfolio of 1.6T networki

gurufocus.com · 5 jun

Dolby Vision and Dolby Atmos to Power Telemundo's FIFA World Cup 2026™ Coverage on Peacock, a Streaming First

Dolby Vision and Dolby Atmos to Power Telemundo's FIFA World Cup 2026™ Coverage on Peacock, a Streaming First PR Newswire

seekingalpha.com · 4 jun

Dolby Laboratories, Inc. (DLB) Presents at 2026 Baird Global Consumer, Technology & Services Conference Transcript

Dolby Laboratories, Inc. (DLB) Presents at 2026 Baird Global Consumer, Technology & Services Conference Transcript

seekingalpha.com · 3 jun

Dolby Laboratories, Inc. (DLB) Presents at 46th Annual William Blair Growth Stock Conference Transcript

Dolby Laboratories, Inc. (DLB) Presents at 46th Annual William Blair Growth Stock Conference Transcript

gurufocus.com · 1 jun

GE HealthCare Focuses on Expanding Access to Nuclear Medicine Through AI, Radiopharmaceutical and Imaging Innovations

As theranostics adoption acceleratesi and radiopharmaceutical demand grows,ii healthcare systems are under increasing pressure to scale nuclear medicine operat